Hormone receptor and human epidermal growth factor receptor 2 detection in invasive breast carcinoma: a retrospective study of 12,467 patients from 19 Chinese …

R Shui, X Liang, X Li, Y Liu, H Li, E Xu, Z Zhang… - Clinical breast …, 2020 - Elsevier
Introduction We evaluated the current status of hormone receptor (HR) and human
epidermal growth factor receptor 2 (HER2) detection in invasive breast carcinoma (IBC) in …

Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 …

R Shui, X Liang, X Li, Y Liu, H Li, E Xu… - Clinical breast …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction We evaluated the current status of hormone receptor (HR) and human
epidermal growth factor receptor 2 (HER2) detection in invasive breast carcinoma (IBC) in …

Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 …

R Shui, X Liang, X Li, Y Liu, H Li, E Xu… - Clinical Breast …, 2020 - clinical-breast-cancer.com
Introduction We evaluated the current status of hormone receptor (HR) and human
epidermal growth factor receptor 2 (HER2) detection in invasive breast carcinoma (IBC) in …

Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 …

R Shui, X Liang, X Li, Y Liu, H Li, E Xu… - Clinical Breast …, 2019 - europepmc.org
Materials and methods The Breast Pathology Study Group of the Chinese Society of
Pathologists collected HR and HER2 data from 12,467 IBC cases from 19 representative …